PHILADELPHIA, PA, September 04, 2013 /24-7PressRelease/
, a noted compound and specialty pharmacy, has long served the best interests of its patients in order to provide them with the highest degree of service possible--and allow them to access the healthcare resources they require to obtain a higher degree of wellbeing and and improved quality of life. As a trusted provider associated with various insurance companies, QmedRx is devastated to hear of the cuts that have been made (and that are still being considered) to the TRICARE program.
published by Stars and Stripes highlights one of the most troublesome coverage reductions that have been made: the limitation of access to applied behavioral analysis for children with autism. Considered the best treatment option for autism in today's healthcare industry, applied behavioral analysis (ABA) is a time-intensive therapy that is recommended for children who suffer from this condition. The new TRICARE guidelines "require standardized testing for autistic children every six months, and require the children to demonstrate progress to continue receiving [ABA] treatment [...] The rules also require anyone who wants more than two years of the treatment to go through a waiver process and cut off care after 16 years old."
This is an issue that is highly worrisome to Autism Speaks, which is a leading advocacy organization. In addition to limiting the therapy that is available to military families, the TRICARE program is also creating new administrative challenges that can slow progress with regard to gaining approval for treatment coverage.
Another change in TRICARE benefits that has the professionals at QmedRx extremely concerned is the proposal to stop covering compounded pharmaceuticals. This was a change that was initially slated to go into effect in July but that lawmakers agreed to reconsider. Ultimately, compounded medications allow individuals who have allergies and other extenuating circumstances to access the medications they need. Without coverage of these pharmaceuticals, many individuals will not be able to afford their medications, meaning that they will not be able to undergo treatment for their illnesses. Essentially, this is going to harm a wide range of people who rely on compounded medications for everything from basic comfort to survival.
The fact that lawmakers agreed to reconsider the decision is a positive indication that they are willing to listen to the needs of the people; however, this means that the people cannot stop protesting this decision. It is important that individuals speak out about the crucial nature of compounded medications in order to support efforts to have this decision overturned. QmedRx urges individuals to contact their representatives today and explain just how important TRICARE coverage of compounded pharmaceuticals is.
is a compound and specialty pharmacy that offers patients access to personalized pharmaceuticals. These medications are prepared to meet the individual needs of patients who are allergic to certain ingredients or require that their medication be provided in a certain form that differs from that which is mass produced. Established in 1990, the company has served its patients for over 20 years and is a trusted resource for healthcare professionals and insurance providers, as well. In addition to general compounding activity, the professionals at this organization provide transdermal pain and scar relief, sinus care, Lyme disease treatment, wound care, and resources regarding nutrition and podiatry.